comparemela.com

Latest Breaking News On - Salarius pharmaceuticals inc - Page 1 : comparemela.com

Head-To-Head Contrast: Salarius Pharmaceuticals (NASDAQ:SLRX) and Sonnet BioTherapeutics (NASDAQ:SONN)

Salarius Pharmaceuticals (NASDAQ:SLRX – Get Free Report) and Sonnet BioTherapeutics (NASDAQ:SONN – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends. Profitability This table compares Salarius Pharmaceuticals and […]

New-jersey
United-states
Houston
Texas
Life-therapeutics-pte
University-of-utah-research-foundation
Salarius-pharmaceuticals-inc
Research-institute-of-texas
News-ratings-for-salarius-pharmaceuticals-daily
Sonnet-biotherapeutics-holdings-inc
Salarius-pharmaceuticals

Salarius Pharmaceuticals (NASDAQ:SLRX) Stock Price Up 7.5%

Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX – Get Free Report)’s share price rose 7.5% during trading on Wednesday . The stock traded as high as $0.54 and last traded at $0.54. Approximately 39,529 shares traded hands during mid-day trading, a decline of 58% from the average daily volume of 93,379 shares. The stock had previously closed at […]

Institutional-trading-of-salarius-pharmaceuticals
Salarius-pharmaceuticals-inc
Salarius-pharmaceuticals-company-profile
Salarius-pharmaceuticals-stock
Salarius-pharmaceuticals
Armistice-capital
News-ratings-for-salarius-pharmaceuticals-daily
Exchange-commission
Nasdaq
Get-free-report
Free-report

North American Morning Briefing : Tech in Focus on -2- - 2024-03-25

Today the House, where Republicans have a 218-213 margin, is functioning more like an informal coalition government than a GOP-run chamber, with Speaker Mike Johnson buffeted by warring factions. -March 25, 2024 at 06:06 am EDT - MarketScreener

Westport
Newfoundland
Canada
Texas
United-states
California
Tokyo
Japan
Mizuho
Hokkaido
United-kingdom
James-river

vimarsana © 2020. All Rights Reserved.